STJ  St. Jude Medical Inc.




Health Care


Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market Cap.


Vuru Grade


Current Price

+0.51 (+0.69%)

Growth Price

Overvalued by 28.20%

Stability Price

Overvalued by 72.73%

Company Metrics

  • 21.08 P/E
  • 3.76 P/S
  • 5.43 P/B
  • 3.51 EPS
  • 14.54% Cash ROIC
  • 0.54 Cash Ratio
  • 1.16 / 1.7% Dividend
  • 2.09M Avg. Vol.
  • 21.24B Market Cap.

Company Description

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. The Cardiac Rhythm Management segment offers products for cardiac arrhythmias, or irregular heart beats. Its products include tachycardia implantab...

Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow


New Partnership Between St. Jude Medical and Mended Little Hearts Benefits ...
Business Wire (press release) - 8 hours ago
A new initiative by the non-profit Mended Little Hearts and St. Jude Medical, Inc., a global medical device manufacturer, will offer an important new online resource for parents and caregivers of children undergoing pediatric cardiology procedures.
St. Jude Medical Cuts Earnings Forecast Amid Currency Impacts
Wall Street Journal - Apr 22, 2015
For the full year, St. Jude Medical STJ -0.73 % said Wednesday that it now expects adjusted earnings of $3.92 to $3.97 a share, down from its previous guidance of $3.95 to $4 a share.
Share “St. Jude Medical climbs to all-time highs...” -
St. Jude Medical Price Target Raised to $73.00 at Jefferies Group (STJ) - WKRB News
St. Jude Medical (STJ) Looks Good: Stock Gains 6.4% - Apr 23, 2015
St. Jude Medical Inc. (STJ - Analyst Report) was a big mover last session, as the company saw its shares rise over 6% on the day.
St. Jude Medical (STJ) Looks Good: Stock Gains 6.4% - Tale of the Tape - Nasdaq
Will St. Jude Medicals (STJ) Earnings Miss the Mark in Q1? - Apr 20, 2015
St. Jude Medical Inc. (STJ - Analyst Report) is slated to release its first-quarter 2015 earnings results on Apr 22.
Will St. Jude Medical's (STJ) Earnings Miss the Mark in Q1? - Analyst Blog - Nasdaq
5 Healthcare Sector NEWS Alert: Abbott Laboratories (ABT), St. Jude Medical ...
wsnewspublishers - Apr 22, 2015
Commenting on the company's financial results, St. Jude Medical Chairman, President and Chief Executive Officer Daniel J. Starks said, “St. Jude Medical's first quarter revenue exceeded formerly declared guidance, driven by our growth in atrial ...
Deal or No Deal, Stick With Mylan -
St. Jude Medical Now #252 Largest Company, Surpassing Intuitive Surgical
Forbes - Apr 8, 2015
Market capitalization is an important data point for investors to keep an eye on, for various reasons. The most basic reason is that it gives a true comparison of the value attributed by the stock market to a given company's stock. Many beginning ...
St. Jude Medical Given a $86.00 Price Target at Needham & Company LLC (STJ)
Dakota Financial News - Apr 23, 2015
St. Jude Medical, Inc. logo Needham & Company LLC set a $86.00 price target on St. Jude Medical (NYSE:STJ) in a research report sent to investors on Wednesday morning.
St. Jude tops Street 1Q forecasts - Apr 22, 2015
ST. PAUL, Minn. - St. Jude Medical Inc. (STJ) on Wednesday reported first-quarter net income of $262 million. The St. Paul, Minnesota-based company said it had profit of 91 cents per share.
Analysts' Weekly Ratings Updates for St. Jude Medical (STJ)
Dakota Financial News - Apr 24, 2015
4/22/2015 - St. Jude Medical was given a new $86.00 price target on by analysts at Needham & Company LLC.
Piper Jaffray Increases St. Jude Medical Price Target to $84.00 (STJ)
Dakota Financial News - Apr 25, 2015
St. Jude Medical (NYSE:STJ) opened at 73.47 on Thursday. St. Jude Medical has a 52-week low of $54.80 and a 52-week high of $75.73.